NextCure (NXTC) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

Net buying: insiders sold $0 and bought $140K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$140K net
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about NXTC filings

Are insiders buying or selling NextCure Inc (NXTC) stock?

Net buying: insiders sold $0 and bought $140K of NXTC stock on the open market in the 90 days to Nov 14, 2026, according to SEC Form 4 filings. The largest was Adar1 Capital Management, LLC (10% owner), who bought $140K. The latest filing was on Nov 13, 2026.

Which members of Congress have traded NXTC recently?

None. No member of Congress disclosed a NXTC trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this NXTC smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Filings could not be loaded.

6 funds hold a position and insiders have been net buying.

Questions about NXTC filings

Are insiders buying or selling NextCure Inc (NXTC) stock?

Which members of Congress have traded NXTC recently?

None. No member of Congress disclosed a NXTC trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this NXTC smart-money data?

Insiders

What insiders are doing

6 trades · 6 mo

Bought$1.9MSold$185K

Buys (3)

AC
Adar1 Capital Management, Llc
10% · Nov 13
$63K
bought
Signals like this: n=2459, 52% finished lower at D15, median -0.4% vs SPY +0.2%
AC
Adar1 Capital Management, Llc
10% · Nov 9
$24K
bought
AC
Adar1 Capital Management, Llc
10% · Oct 27
$54K
bought
Signals like this: n=2459, 52% finished lower at D15, median -0.4% vs SPY +0.2%

2 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 trades

Other smart money signals

Activist stakes, short interest & more

2 items

F1
Filing 13d GModerate
Affinity Asset Advisors, LLC filed SC 13G/A on NextCure, Inc. (passive 9.99% stake)
F1
Filing 13d GModerate
JP Sailing Capital Ltd filed SC 13G on NextCure, Inc. (passive 9.90% stake)

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 10, 2026

Earnings landed in line with what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 10, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.90-0.49% in line

-$0.90 expected

Revenue

$0.00

Yahoo Finance

EPS and revenue: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 10, 2026	-$0.90est. -$0.90	-0.49%in line	$0.00Yahoo Finance	No year-ago quarter
Jun 30, 2026Reported Aug 6, 2026	-$1.84est. -$1.98	+7.07%beat	Not on file	Not on file
Mar 31, 2026Reported May 7, 2026	-$1.87est. -$2.03	+7.88%beat	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Mar 5, 2026	-$0.81est. -$2.29	+64.63%beat	Not on file	Not on file
Sep 30, 2025Reported Nov 5, 2025	-$3.22est. -$3.98	+19.16%beat	Not on file	Not on file
Jun 30, 2025Reported Aug 7, 2025	-$11.29est. -$4.62	-144.37%miss	Not on file	Not on file
Mar 31, 2025Reported May 1, 2025	-$4.68est. -$4.80	+2.50%beat	Not on file	Not on file
Dec 31, 2024Reported Mar 6, 2025	-$0.41est. -$0.36	-13.89%miss	Not on file	Not on file

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $5.95
High: $6.36
Low: $5.37
Prev close: $5.98
52-wk high: $15.74
52-wk low: $1.55
Mkt cap: $27.4M
ROE: -204.6%
Beta: 1.20
P/S: 9.5x
P/B: 2.3x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $27M

Valuation

P/S9.52
P/B2.25

Quality

Operating margin0.0%
ROE-204.6%
ROA-69.0%

Growth

Beta1.20

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

62balanced

20D volatility

129%annualized

52-week range

$6.23

$1.55$15.74

20D support

$4.53recent floor

20D resistance

$6.66recent ceiling

Returns

5D +21.7%20D -9.4%60D -8.1%

Price vs moving averages

SMA20 +8.4%SMA50 +3.6%SMA200 -17.5%

Volume pace

0.62xvs prior 20D

12 macro signals shaping NXTC right now

Unlock sector rotation, regime shifts, and macro event windows tied to this stock.

Unlock the full results

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 10, 2026

-$0.90est. -$0.90

-0.49%

$0.00Yahoo Finance

No year-ago quarter

Jun 30, 2026Aug 6, 2026

-$1.84est. -$1.98

+7.07%

Not on file

Mar 31, 2026May 7, 2026

-$1.87est. -$2.03

+7.88%

$0.00Yahoo Finance

No year-ago quarter

Dec 31, 2025Mar 5, 2026

-$0.81est. -$2.29

+64.63%

Not on file

Sep 30, 2025Nov 5, 2025

-$3.22est. -$3.98

+19.16%

Not on file

Jun 30, 2025Aug 7, 2025

-$11.29est. -$4.62

-144.37%

Not on file

Mar 31, 2025May 1, 2025

-$4.68est. -$4.80

+2.50%

Not on file

Dec 31, 2024Mar 6, 2025

-$0.41est. -$0.36

-13.89%

Not on file

NextCure Inc

Smart money at a glance

What do analysts expect?

Questions about NXTC filings

Questions about NXTC filings

What insiders are doing

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Earnings landed in line with what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

NextCure Inc

Smart money at a glance

What do analysts expect?

Questions about NXTC filings

Questions about NXTC filings

What insiders are doing

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Earnings landed in line with what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

NextCure Inc

Overview

Questions about NXTC filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.

NextCure Inc

Overview

Questions about NXTC filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.